ADMA BIOLOGICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
ADMA BIOLOGICS, INC. (ADMA) had Common Stock, Capital Shares Reserved for Future Issuance of 52.84 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Equity › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-05
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 52.84M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 46.00M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 38.70M shares.
- 2024-12-31: Common Stock, Capital Shares Reserved for Future Issuance 36.09M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance |
|---|---|
| 2026-06-30 | 52.84M shares 10-Q · filed 2026-08-05 |
| 2026-03-31 | 46.00M shares 10-Q · filed 2026-05-06 |
| 2025-12-31 | 38.70M shares 10-K · filed 2026-02-25 |
| 2024-12-31 | 36.09M shares 10-K · filed 2025-03-18 |
| 2024-09-30 | 35.86M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 35.57M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 34.63M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 31.03M shares 10-K · filed 2024-02-28 |
| 2023-09-30 | 30.95M shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 28.53M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 29.38M shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 29.18M shares 10-K · filed 2023-03-23 |
| 2022-09-30 | 53.27M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 53.12M shares 10-Q · filed 2022-08-10 |
| 2022-03-31 | 70.84M shares 10-Q · filed 2022-05-11 |
| 2021-12-31 | 87.24M shares 10-K · filed 2022-03-24 |
| 2021-09-30 | 144.64M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 151.05M shares 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |